Gainers
- Precision BioSciences DTIL stock increased by 6.6% to $1.29 during Monday's after-market session. The company's market cap stands at $143.1 million.
- Benitec Biopharma BNTC stock moved upwards by 4.65% to $0.27. The company's market cap stands at $7.5 million.
- Trevena TRVN shares rose 4.63% to $1.58. The company's market cap stands at $12.1 million.
- Lixte Biotech Hldgs LIXT stock moved upwards by 4.62% to $0.85. The company's market cap stands at $14.1 million.
- X4 Pharmaceuticals XFOR shares rose 4.53% to $1.04. The company's market cap stands at $126.3 million.
- Adamis Pharmaceuticals ADMP stock moved upwards by 4.18% to $0.23. The company's market cap stands at $34.3 million.
Losers
- Collegium Pharmaceutical COLL stock fell 9.9% to $25.0 during Monday's after-market session. The company's market cap stands at $839.2 million.
- Rubius Therapeutics RUBY shares declined by 8.07% to $0.31. The market value of their outstanding shares is at $28.0 million.
- Cardio Diagnostics Hldgs CDIO stock fell 8.03% to $1.72. This security traded at a volume of 107.4K shares come close, making up 72.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $16.3 million.
- Quoin Pharmaceuticals QNRX stock declined by 5.79% to $2.28. The market value of their outstanding shares is at $11.0 million.
- 9 Meters Biopharma NMTR shares fell 4.99% to $2.48. The market value of their outstanding shares is at $32.1 million.
- Humanigen HGEN stock declined by 4.94% to $0.21. Today's trading volume for this security ended up closing at 514.9K shares, which is 18.4 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $25.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in